Management Team

Martin Åmark

CEO & Head of Investor Relations

Since 2015

Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including life science and pharmaceuticals.

Shares: 154,646
Warrants: 24,000

Siavash Bashiri

COO & Head of Biosimilars

Since 2015

Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.

Shares: 110,970
Warrants: 7,000

Dr. David Vikström

CTO

Since 2014

David Vikström is the CTO of Xbrane Bioscience. He has a Ph.D. in expression and targeting of proteins in E. coli. He joined Xbrane in 2010 and successfully developed new technologies and strains for vaccine candidates. He is currently heading the development of Xbrane’s new expression systems to be able to take the expression in E. coli to new levels.

Shares: 32,518
Warrants: 24,000

Anders Wallström

Head of Manufacturing and Supply Chain

Since 2019

Anders Wallström holds a M. Sc. in Biotechnology from Royal Institute of Technology in Stockholm. He has more than 20 years of experience from process development, manufacturing and validation at SOBI and Biovitrum. Furthermore, he has significant experience from coordinating contract manufacturers for commercial products for both small molecule and biotech products.

Shares: 3,003
Warrants: –

Margareta Hagman

Interim CFO

Since September 2020

Margareta Hagman holds a Master of Business Administration from Örebro University. Active as advisor and consultant in accounting and finance. Board member of Infant Therapeutics Baby (IBT) AB and Tagmaster AB. Previously CFO and Deputy CEO of BioGaia AB.

Shares: 1,000
Warrants: –

Dina Jurman

Head of Clinical Affairs

Since 2017

Dina Jurman holds a M.Sc. in Biomedicine from Uppsala University and has previously worked as Director Clinical Operations at IRW Consulting AB as well as Clinical Operations Manager consultant at Amgen Sweden.

Shares: 420
Warrants: –

Maria Edebrink

Head of Regulatory Affairs

Since 2019

Maria Edebrink holds a M. Sc. in Chemistry from Stockholm University. She has 28 years of experience from Pharmaceutical Development and CMC Regulatory Affairs working for AstraZeneca, Galderma and Medivir. Her experience covers biotech products, small molecules, medical devices and cosmetics from early to late stage development through to commercial manufacturing.

Shares: 6,555
Warrants: –

Xiaoli Hu

Head of Business Development

Since 2020

Xiaoli has a Medical Doctor degree from Shanghai Jiao Tong University as well as a Ph.D in Medical Science from Karolinska Institutet. Xiaoli has experience in business development from the pharmaceutical industry, most recently as Head of Business Development at Affibody, where she led the work on the commercial partnership agreement of USD 650 million with Alexion and the co-development agreement with GE Healthcare. Prior to that, Xiaoli spent almost four years on HealthCap, a leading Nordic health and healthcare investor.

Shares: –
Warrants: –